the chronic phase of infection. Together, these results suggest a complex role for apoptosis in tuberculosis, with benefits to either host or pathogen that depend on the stage of infection and the confluence of innate and adaptive immunity.
One feature of the zebrafish embryo model is the absence of adaptive immune cells; although this simplifies analysis of the early events in granuloma induction, it leaves many opportunities for studies in mice to define the interactions between infected phagocytes and T and B lymphocytes, such as those pioneered by Egen and colleagues. In particular, it will be essential to define the frequency of productive interactions of antigenspecific CD4 + and CD8 + T cells with mycobacterium-infected macrophages and dendritic cells in vivo. This will help determine whether some of the success of mycobacteria is due to their interfering with recognition of infected cells by antigen-specific lymphocytes. Another event noted by Davis and Ramakrishnan is the egress of infected macrophages from established granulomas. During the early stages of infection, this is a mechanism for establishing secondary granulomas; does the same mechanism account for egress of infected dendritic cells and their migration to lymph nodes to activate antigen-specific T cells later in infection (Wolf et al., 2008) ? Understanding this process could help uncover the cause for the delay in initiation of adaptive immunity to M. tuberculosis and could provide valuable information for development of improved tuberculosis vaccines.
Advances in intravital imaging have already made major contributions to understanding cellular dynamics in mycobacterial granulomas, including observations that question the long-held tenet that granulomas only benefit the host. We can look forward to additional insights from imaging studies that will further refine our knowledge of the complex interactions between pathogen and host in tuberculosis and lead to new ways to perturb the equilibrium to our advantage. 
Both
Sir2-related NAD + -dependent protein deacetylases (sirtuins) and the NF-κB family of transcription factors have been implicated in complex biological processes such as metabolism, inflammation, cellular senescence, and aging. However, there has been no evidence linking these two families of transcriptional regulators. Reporting in this issue of Cell, Kawahara et al. (2009) now demonstrate that depletion of NF-κB reverses the degenerative phenotype of mice lacking Sirt6, suggesting that an essential homeostatic function of SIRT6 is to prevent hyperinduction of NF-κB-dependent genes. This inhibition is mediated by the recruitment of SIRT6 to chromatin through interactions with NF-κB, resulting in deacetylation of histone H3 lysine 9 (H3K9) and destabilization of NF-κB binding (Figure 1 ).
In yeast, Sir proteins promote longevity by silencing repeat sequences (mating type loci, ribosomal DNA repeats, and subtelomeric regions), a task that requires NAD + -dependent histone deacetylation and chromatin compaction (Blander and Guarente, 2004) . Mutation of Sir2 increases homologous recombination at rDNA repeats, causing the accumulation of toxic extrachromosomal rDNA circles that shorten life span. Sir2 overexpression has the opposite effect on repeat sequence stability, suggesting that Sir2 is a rate-limiting factor in the When sirtuins and nf-κB collide Gioacchino Natoli 1, * regulation of yeast life span. In mammals, there are seven Sir2 orthologs (SIRT1-7) with SIRT1 being the most extensively studied (Blander and Guarente, 2004) . Mice lacking Sirt1 do not show defects that resemble accelerated aging; enforced Sirt1 expression in mice promotes survival and prevents agingassociated transcriptional changes (Oberdoerffer et al., 2008) . SIRT1 also silences repeat sequences in mouse embryonic stem cells, suggesting that some functions of yeast Sir2 regarding control of DNA repeats and life span are conserved in the sirtuins of mammals (Oberdoerffer et al., 2008) . Although the phenotype of Sirt1 −/− knockout mice seems to have little to do with premature aging, Sirt6 −/− mice display a complex degenerative phenotype that has been interpreted to have features of premature aging. Sirt6 −/− mice are normal at birth but soon exhibit stunted growth, lymphopenia, loss of subcutaneous fat, colitis, and osteopenia (leading to skeletal abnormalities). Sirt6 −/− mice are also severely hypoglycemic and downregulate the anabolic signaling pathways that are driven by insulin and insulin-like growth factor 1 (IGF1) (Mostoslavsky et al., 2006) . These various defects result in death of the mice 3-4 weeks after birth. Given that aging-associated transcriptional changes include the induction of NF-κB-regulated genes (Adler et al., 2007) , Kawahara et al. (2009) 
crossed

Sirt6
−/− mice with mice harboring only one copy of the RelA gene (which encodes a subunit of NF-κB) to determine whether the two pathways are somehow linked. Remarkably, the phenotype of the Sirt6 −/− /RelA +/− mice was only marginally affected in the first weeks after birth and then progressively improved with 40% of these animals surviving without apparent problems for more than 100 days. This striking impact of NF-κB deficiency on the phenotype of Sirt6 −/− mice raises some challenging questions: How do the NF-κB and SIRT6 pathways interact and what is the function of this regulation?
Two biochemical functions have been ascribed to SIRT6: ADP ribosylation and NAD + -dependent deacetylation of H3K9 (Liszt et al., 2005; Michishita et al., 2008) . Kawahara et al. (2009) report that mouse SIRT6 physically interacts with the RELA subunit of NF-κB and is recruited to NF-κB target promoters. SIRT6-deficient cells show hyperacetylation of H3K9 at a subset of NF-κB target promoters. The authors also find a corresponding increase in RELA occupancy at these promoters, as well as elevated expression of NF-κB target genes. Thus, the convergence of SIRT6 and NF-κB at certain NF-κB-regulated genes seems to result in SIRT6-mediated dampening of the expression of those genes ( Figure  1 ). How does this newfound regulatory mechanism fit into the context of aging? If the phenotype of Sirt6 −/− mice is the consequence of multiorgan degeneration associated with premature aging, the role played by NF-κB in this phenotype may be interpreted as a manifestation of its ability to promote aging-associated changes in gene expression (Figure 1) . Indeed, NF-κB-dependent gene expression is known to increase in aged tissues (Adler et al., 2007) .
The defects observed in the Sirt6 −/− mouse, however, may in fact not be indicative of premature aging. The mechanistic link between SIRT6 and premature aging originally stemmed from the proposed role of SIRT6 in controlling genomic stability. Indirect evidence first suggested a role for SIRT6 in base excision repair (Mostoslavsky et al., 2006) . Then, SIRT6 was shown to deacetylate the chromatin in telomeres and to control the recruitment to telomeres of the Werner helicase (Wrn), which is essential for maintaining telomere integrity (Michishita et al., 2008) . Given that defects in DNA damage detection and repair cause premature aging, multiorgan deterioration in Sirt6 −/− mice was interpreted as an aging phenotype (Mostoslavsky et al., 2006) . However, this conclusion requires a leap of logic. First, defects in base excision repair are not a known cause of premature aging. Second, Sirt6 deficiency is unlikely to cause detrimental effects on the long telomeres of mice. In fact, loss of the Wrn helicase in mice causes premature aging only if telomerase is also lost. Third, metabolism plays an important role in aging (Vijg and Suh, 2005) , and the phenotype of Sirt6 −/− mice is dominated by metabolic problems that cannot be solely explained by SIRT6's role in maintaining genomic stability.
The existence of a strong metabolic component to the Sirt6 −/− phenotype is not surprising considering that SIRT6 is an NAD + -dependent enzyme and is therefore a sensor of the energy and redox states of the cell. But, the mechanism that explains how SIRT6 deficiency results in hypoglycemia, which in turn leads to reduced IGF1 and insulin levels, remains unclear. The consequences of deregulating NF-κB target gene expression also cannot explain all aspects of the Sirt6 −/− phenotype. Mice with an overactive NF-κB pathway show stunted growth (Lee et al., 2000) , reminiscent of that observed in Sirt6 −/− mice. This may SIRT6 is an NAD + -dependent deacetylase that is recruited to chromatin through direct interactions with the transcription factor NF-κB. SIRT6 antagonizes NF-κB-induced gene expression programs (including those involved in aging) by associating with chromatin-bound NF-κB, directing deacetylation of histone H3 lysine 9 (H3K9), and destabilizing binding of NF-κB to chromatin.
be caused by extensive inflammation that results in energy being diverted from anabolic pathways to inflammatory cells. Interestingly, upregulation of NF-κB signaling does not result in hypoglycemia but in the opposite, that is, insulin resistance leading to increases in blood glucose and insulin (Hotamisligil, 2006) . This is consistent with the inability of RelA haploinsufficiency to rescue the hypoglycemic phenotype of Sirt6 −/− mice during the first few weeks after birth. The precise biological role of SIRT6 in the regulation of NF-κB thus remains unclear. Although SIRT6 dampens NF-κB-dependent gene expression, it may not be a specific inhibitor of the NF-κB pathway. The initial trigger resulting in the phenotype of Sirt6 −/− mice is unlikely to be the direct result of disrupting negative control of the NF-κB system. These considerations suggest an alternative explanation of the data, namely that loss of SIRT6 could result in NF-κB-independent nonlethal abnormalities that are then greatly exacerbated by the upregulation of NF-κB target genes, resulting in multiorgan failure and death. What might these abnormalities be? The uniform kinetics of multiorgan deterioration and death in Sirt6 −/− mice (which die 20-28 days after birth) suggest that Sirt6 deletion disrupts a crucial transition at a precise stage of postnatal development.
In this light, it is worth noting that Sirt6 −/− mice show an erosive colitis resulting in death around the time of weaning, when the gut microbiota undergoes major changes. Thus, one interesting possibility is that the erosive colitis found in Sirt6 −/− mice predisposes them to intestinal infections at a time when the immuneprotective role of maternal milk has ceased and new microbes are introduced into the gut with food. Under these conditions of infection at an extensively eroded mucosa, deregulation of NF-κB target gene expression (which results in excessive inflammation) may lead to a lethal outcome. Consistent with this notion, the phenotypic rescue due to RelA haploinsufficiency is also observed at this stage of mouse postnatal development and not in the first 3 weeks after birth.
Microbe-triggered inflammatory responses evolved in multicellular organisms and are essential for survival. Successful antimicrobial responses require that energy sources be redirected from other biological processes (such as anabolic pathways) to support the activities of inflammatory cells; NF-κB and SIRT6 are two essential components of this interface between metabolism and inflammation. The Kawahara et al. study now suggests that these two proteins connect inflammation and metabolism to aging-associated gene expression programs, thus providing a busy crossroads for several key pathways.
